Rockville company forms scientific advisory board on inflammatory and immunological diseases

AbelZeta Pharma Inc., a global clinical-stage biopharmaceutical company with its U.S. headquarters in Rockville and focused on discovery and development of innovative and proprietary cell-based therapeutic products, announced Wednesday the formation of a scientific advisory board (SAB) to advance its cell therapies for the treatment of inflammatory and immunological diseases.